Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Adventitious virus contamination is one of the most subtle risks in mammalian cell banks. Viruses can enter through infected animal tissues, contaminated raw materials (such as serum and trypsin), or cross-contamination during cell processing. Unlike endogenous retroviruses that are carried by the cell genome, adventitious viruses are unintentionally introduced and may not cause immediate cytopathic effects, making them difficult to detect.
| Method | Principle | Detection Scope | Turnaround | Regulatory Status |
| In vitro co-culture | Amplify virus on indicator cells (MRC-5, Vero, L929) | Replicable viruses – broad spectrum, including unknown viruses | 28 days | ICH Q5A(R2) mandatory |
| In vivo (MAP/HAP/RAP) | Animal antibody response to virus | Rodent-specific viruses (MAP covers 17 viruses) | 6–8 weeks | ICH Q5A(R2) mandatory for rodent cells |
| TEM | Direct morphology (ultrathin section or negative stain) | Virus particles, retrovirus-like particles | 1–2 weeks | USP/EP/ChP recognized |
| qPCR/ddPCR | Targeted nucleic acid amplification | Specific known viruses | 1–2 days | ICH Q5A(R2) accepted |
| NGS | Whole-genome sequencing | Known + unknown viruses (unbiased) | 2–4 weeks | ICH Q5A(R2) accepted (needs validation) |
The in vitro and in vivo assays are broad-spectrum systems capable of detecting non-specific, unexpected viruses – an advantage that targeted qPCR cannot offer. TEM provides direct visualization, while NGS enables unbiased discovery of novel viruses.
All methods at Creative Biogene are validated according to ICH Q5A(R2), USP <1237>, and EP 5.2.3. We provide complete validation documents and test reports supporting IND/BLA submissions.
Key regulatory references
Mandatory testing per ICH Q5A(R2)
Acceptance criteria
Need a customized adventitious virus testing plan for your cell bank? Our technical team will design a strategy based on your cell type, passage history, and regulatory stage.
Q: Can NGS replace in vivo MAP/HAP/RAP?
A: ICH Q5A(R2) accepts NGS as an alternative method, but it must be properly validated. Studies show NGS can detect all 19 rodent viruses plus additional ones within 3 weeks, compared to 8 weeks for MAP. However, regulators currently view NGS as a supplement rather than a full replacement. Creative Biogene recommends traditional methods for release testing and NGS for deep characterization.
Q: Why is TEM still needed when we have NGS?
A: TEM directly visualizes virus particles, including retrovirus-like particles (RVLPs) that are commonly present in CHO cells. It is the only method that provides morphological evidence and can quantify particle numbers. NGS detects nucleic acid but cannot distinguish an intact infectious virus from fragmented DNA. TEM remains valuable for retrovirus screening.
Q: What happens if a test comes back positive for adventitious virus?
A: A positive result is a lot-of rejection criteria. The process includes: confirm by repeat testing; identify the virus (PCR/sequencing/TEM); perform a risk assessment; discard the cell bank and rebuild from a clean source; implement corrective and preventive actions. Creative Biogene can assist with virus identification and risk assessment.
Copyright © 2026 Creative Biogene. All rights reserved.